Five Common Falsehoods About Alzheimer’s Disease

Alzheimer; News from the web:

The Alzheimer’s Foundation of America (AFA) is providing information to dispel common falsehoods about Alzheimer’s disease to help individuals know the warning signs, understand the importance of early detection, and learn how to be proactive about reducing their risk.

“Dispelling the misconceptions about Alzheimer’s disease is critically important, because they may cause people to ignore symptoms and delay taking action which impacts their health and quality of life,” said Charles J. Fuschillo, Jr., AFA’s President & CEO. “National Alzheimer’s Awareness Month is the perfect time to reinforce factual information that can help someone spot the warning signs, get screened, and be proactive about their brain health.”

Read all about it HERE

How about Alzheimer’s villages?

Alzheimer; News from the web:

A small village in Dax, France, is working to find a better way to handle the increasing caseload. In one of the first research projects of its kind, the small town houses around 110 people with early- to late-stage Alzheimer’s who are free to roam and visit the village’s supermarket, hairdresser, restaurant, café, library, and music hall. With a daily cost of €65 ($75), the program aims to allow people to exist with greater autonomy, purpose, and freedom without facing immediate financial hardship. “If it is not for everyone, it doesn’t work,” said Mathilde Charon-Burnel, a spokesperson for the experiment.

Read all about it HERE

Alzheimer’s and Covid; a connection found

Alzheimer; News from the web:

Researchers have identified a genetic link between Alzheimer’s and severe cases of COVID-19 that may open new avenues into the treatment of both diseases.

The study, published in the journal Brain , found that the presence of a variant of the OAS1 gene increases the risk of developing Alzheimer’s disease by three to six per cent, while similar variants of the same gene increase the odds of contracting a case of severe COVID. In addition to presenting new possibilities for treatment, researchers hope this overlap may shed light on other infectious diseases and dementias.

Read all about it HERE

Free app for Alzheimer’s patients

Alzheimer; News from the web:

Great initiative by two young inventors, a free app for people with Alzheimer’s.

Just made for the greater good, the boys do not make a penny out of it.

Read all about it HERE

Alzheimer’s therapy for people with Down syndrome

Alzheimer; News from the web:

Researchers at the University of Colorado School of Medicine have been awarded a $4.6 million, five-year grant by the National Institute on Aging to study whether a potential Alzheimer’s disease treatment is safe and effective in improving cognitive function in young adults with Down syndrome.

Huntington Potter, PhD, professor of neurology, and Peter Pressman, MD, assistant professor of neurology, are principal investigators on the study of sargramostim, which is also know by the brand name Leukine, an FDA-approved drug with nearly 30 years of safe use in numerous patient populations.

“This is the first clinical trial in years to target cognition in people with Down syndrome,” said Potter, who is director of University of Colorado Alzheimer’s and Cognition Center. “We are breaking new ground in studying both of these disorders – Down syndrome and Alzheimer’s disease. We hope that this therapy will greatly improve their quality of life.”

Read all about it HERE